Archive | Updates RSS feed for this section

IMBCR Identifies New Treatments for Myeloma in 2015!

July 17, 2015

0 Comments

First, we have made much progress on our new protein marker called B-cell maturation antigen (BCMA) that was initially found in the blood of myeloma patients. The level of this single serum marker predicts patient’s long-term outcomes. It also correlates with how the patient is doing in that very low levels are associated with patients […]

Continue reading...

An Overview of Progress in Myeloma Research with Dr. James Berenson

June 18, 2014

0 Comments

Myeloma news from the 2014 annual meeting of the American Society of Clinical Oncology has included updates on proteasome inhibitors, overcoming drug resistance, monoclonal antibodies and more. In this brief video, Dr. James Berenson, a leading myeloma researcher and physician, gives an overview with a focus on what’s important for patients today. Original Link

Continue reading...

What’s New in Myeloma?

June 27, 2013

0 Comments

There have been several recent breakthroughs for the treatment of multiple myeloma patients that have led to new therapeutic options. With regards to newer agents, there are a number of new drugs in development.  The most promising are the antibody-based treatments for myeloma involving proteins on the outside of myeloma cells that are called CD38, […]

Continue reading...